Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:67-73
Published online before print December 19, 2005, doi: 10.1161/CIRCULATIONAHA.105.569491
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/1/67    most recent
CIRCULATIONAHA.105.569491v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okin, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okin, P. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Failure
*High Blood Pressure
Related Collections
Right arrow Congestive
Right arrow Hypertrophy
Right arrow Electrocardiology
Right arrow Clinical Studies
Right arrowRelated Article

(Circulation. 2006;113:67-73.)
© 2006 American Heart Association, Inc.


Heart Failure

Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients

The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study

Peter M. Okin, MD; Richard B. Devereux, MD; Markku S. Nieminen, MD; Sverker Jern, MD; Lasse Oikarinen, MD; Matti Viitasalo, MD; Lauri Toivonen, MD; Sverre E. Kjeldsen, MD, PhD; Björn Dahlöf, MD, PhD, for the LIFE Study Investigators

From the Greenberg Division of Cardiology, Weill Medical College of Cornell University, New York, NY (P.M.O., R.B.D.); Division of Cardiology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland (M.S.N., L.O., M.V., L.T.); Sahlgrenska University Hospital/Östra, Göteborg, Sweden (S.J., B.D.); and Ulleval University Hospital, Oslo, Norway, and University of Michigan Medical Center, Ann Arbor (S.E.K.).

Correspondence to Peter M. Okin, MD, Weill Medical College of Cornell University, 525 E 68th St, New York, NY 10021. E-mail pokin{at}med.cornell.edu

Received June 16, 2005; revision received October 25, 2005; accepted October 31, 2005.

Background— The ECG strain pattern of ST depression and T-wave inversion is strongly associated with left ventricular hypertrophy (LVH) independently of coronary heart disease and with an increased risk of cardiovascular morbidity and mortality in hypertensive patients. However, whether ECG strain is an independent predictor of new-onset congestive heart failure (CHF) in the setting of aggressive antihypertensive therapy in unclear.

Methods and Results— The relationship of ECG strain at study baseline to the development of CHF was examined in 8696 patients with no history of CHF who were enrolled in the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. All patients had ECG LVH by Cornell product and/or Sokolow-Lyon voltage criteria on a screening ECG, were treated in a blinded manner with atenolol- or losartan-based regimens, and were followed up for a mean of 4.7±1.1 years. Strain was defined as a downsloping convex ST segment with inverted asymmetrical T-wave opposite the QRS axis in lead V5 or V6. ECG strain was present in 923 patients (10.6%), and new-onset CHF occurred in 265 patients (3.0%), 26 of whom had a CHF-related death. Compared with patients who did not develop CHF, hypertensive patients who developed CHF were older; were more likely to be black, current smokers, and diabetic; were more like to have a history of myocardial infarction, ischemic heart disease, stroke, or peripheral vascular disease; and had greater baseline severity of LVH by Cornell product and Sokolow-Lyon voltage, higher baseline body mass indexes, higher serum glucose levels and albuminuria, similar baseline systolic and diastolic pressures, and reductions in diastolic pressure with treatment but greater reductions in systolic pressure. In univariate Cox analyses, ECG strain was a significant predictor of new-onset CHF (hazard ratio [HR], 3.27; 95% CI, 2.49 to 4.29) and CHF mortality (HR, 4.74; 95% CI, 2.11 to 10.64). In Cox multivariable analyses adjusting for baseline differences between patients with and without new-onset CHF, in-treatment differences in systolic and diastolic pressures, Sokolow-Lyon voltage, and Cornell product, and the impact of treatment with losartan versus atenolol on outcomes, ECG strain remained a significant predictor of incident CHF (HR, 1.80; 95% CI, 1.30 to 2.48) and CHF-related death (HR, 2.78; 95% CI, 1.02 to 7.63).

Conclusions— ECG strain identifies hypertensive patients at increased risk of developing CHF and dying as a result of CHF, even in the setting of aggressive blood pressure lowering.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2006 113: 1. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CJASNHome page
V. Krane, F. Heinrich, M. Meesmann, M. Olschewski, J. Lilienthal, C. Angermann, S. Stork, J. Bauersachs, C. Wanner, S. Frantz, et al.
Electrocardiography and Outcome in Patients with Diabetes Mellitus on Maintenance Hemodialysis
Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 394 - 400.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
A. Strand, S.E. Kjeldsen, H. Gudmundsdottir, I. Os, G. Smith, and R. Bjornerheim
Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years
Eur J Echocardiogr, January 1, 2008; 9(1): 34 - 39.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, L. H. Lindholm, B. Dahlof, and for the LIFE Study Investigators
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
Hypertension, November 1, 2007; 50(5): 984 - 990.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
P. M. Okin, R. B. Devereux, K. E. Harris, S. Jern, S. E. Kjeldsen, S. Julius, J. M. Edelman, B. Dahlof, and for the LIFE Study Investigators
Regression of Electrocardiographic Left Ventricular Hypertrophy Is Associated with Less Hospitalization for Heart Failure in Hypertensive Patients
Ann Intern Med, September 4, 2007; 147(5): 311 - 319.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Mihaljevic, B.-K. Lam, J. Rajeswaran, M. Takagaki, M. S. Lauer, A. M. Gillinov, E. H. Blackstone, and B. W. Lytle
Impact of Mitral Valve Annuloplasty Combined With Revascularization in Patients With Functional Ischemic Mitral Regurgitation
J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2191 - 2201.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. H. Lehmann
Prolonged QTc Interval and Sudden Cardiac Death in Older Adults
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1473 - 1474.
[Full Text] [PDF]


Home page
CirculationHome page
S. Stern
Electrocardiogram: Still the Cardiologist's Best Friend
Circulation, May 16, 2006; 113(19): e753 - e756.
[Full Text] [PDF]